Batten–Turner muscular dystrophy

Batten–Turner muscular dystrophy is a rare neuromuscular disorder characterized by progressive muscle weakness and atrophy. It is a form of congenital muscular dystrophy, which means it is present from birth, although symptoms may not become apparent until later in life. This condition is part of a broader category of diseases known as muscular dystrophies, which involve the progressive weakening and loss of muscle mass.

Symptoms and Diagnosis

The primary symptoms of Batten–Turner muscular dystrophy include muscle weakness, particularly in the limbs, and muscle wasting. Over time, individuals with this condition may experience difficulty with movement, and in severe cases, may require assistance for daily activities. Diagnosis is typically made through a combination of clinical examination, family history, and genetic testing. Muscle biopsy and electromyography (EMG) may also be used to assess muscle health and function.

Genetics

Batten–Turner muscular dystrophy is believed to be inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disease. The specific genes involved in Batten–Turner muscular dystrophy have not been definitively identified, making genetic counseling and prediction of the disease more challenging.

Treatment and Management

There is currently no cure for Batten–Turner muscular dystrophy. Treatment focuses on managing symptoms and improving quality of life. This may include physical therapy to maintain muscle strength and flexibility, occupational therapy to assist with daily activities, and the use of assistive devices. In some cases, surgery may be necessary to manage complications such as contractures, which are permanent tightening of muscles or joints.

Prognosis

The prognosis for individuals with Batten–Turner muscular dystrophy varies widely depending on the severity of symptoms and the age of onset. Early intervention with physical and occupational therapy can help to slow the progression of the disease and maintain mobility for as long as possible.

Research

Research into Batten–Turner muscular dystrophy and other forms of muscular dystrophy is ongoing. Scientists are exploring a variety of approaches, including gene therapy, to find effective treatments for these conditions. Clinical trials are an important step in the development of new therapies and may offer hope for individuals affected by muscular dystrophies.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian